hen a person assumes an upright posture, an increase of sympathetic outflow and an inhibition of parasympathetic activity occur reflexly, 1,2 which increases the heart rate and vascular resistance in order to maintain systemic blood pressure. Orthostatic hypotension may be caused by failure of these responses, 3, 4 and for the treatment it is important to select a drug considering its pharmacological properties and the pathophysiology of the disease. At present, vasoconsticting agents are often used for the treatment of orthostatic hypotension. To understand the mechanism of these drugs, their effects not only on systemic blood pressure but also on the vasoconstrictor response to sympathetic stimulation should be examined. However, to our knowledge, such information is limited.
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Amezinium metilsulfate (amezinium) is one of the most popular drugs in Japan for the treatment of orthostatic hypotension. Amezinium has a unique mechanism of vasoconstriction; that is, it inhibits monoamine oxidase (MAO) activity and uptake of noradrenaline, 5, 6 which prompted us to examine whether it influences the vasoconstrictor response to sympathetic stimulation and to -adrenoceptor stimulation by noradrenaline in humans.
To examine the effects of the drug, the following 2 methods were thought to be suitable and were used in the present study, because they are sensitive and noninvasive and are used for the evaluation of autonomic disturbances or orthostatic hypotension. First, the finger-tip vasoconstrictor response to cold stimulation on the contralateral hand was examined using a laser Doppler flowmeter, which is an appropriate means for the study of the vasomotor response mediated by -adrenoceptor stimulation. 7, 8 Second, the venoconstrictor response to locally infused noradrenaline was examined using a linear variable differential transformer (LVDT), which provides a sensitive and easy reproducible means of assessing the effect of a drug on peripheral veins. 9 As the decrease in venous blood return to the heart is involved in the pathogenesis of orthostatic hypotension, 3 it is interesting to also examine the effect of these drugs on veins.
In the present study, we examined, using these methods, the effects of amezinium on the vasoconstrictor responses, and compared them in healthy subjects with those of midodrine hydrochloride (midodrine), an 1-adrenoceptor agonist, 10 which is also a popular drug for orthostatic hypotention.
Methods

Subjects
Eight healthy Japanese males (21-26 years, 64-78 kg) were selected. They were normotensive and nonsmokers, without concomitant medication for at least 2 weeks before the study. The study was approved by the Ethical Committee of Jichi Medical School and all subjects gave their informed consent.
Finger-Tip Blood Flow (FTBF) Measurement
The subjects were comfortably seated with their right arm resting on a table at the heart level. Cutaneous FTBF was recorded from the pad of the right midfinger by a laser Doppler flowmeter (Peri Flux PF3, Perimed, Sweden) with an integrating probe with 7 efferent fibers. Laser Doppler flow was expressed in arbitrary units. The recording of FTBF was started after the subjects rested for more than 10 min, and when the value of FTBF stabilized, cold stimulation was performed by immersing the left hand in ice water (1-3°C) for 15 sec. FTBF rapidly decreased with a latent time of a few seconds and gradually returned to the level before the stimulation.
Dorsal Hand Vein Method
The LVDT used (Schaevits type 025MHR, Pennsauken, NJ, USA) has a freely movable core that rests over the center of the vein to be studied. There is a linear relationship between the vertical movement of the core and the change in voltage output. During the study, the subject was in the supine position with an arm placed on a support sloping upward at an angle of about 30 degrees from the horizontal. In this position, emptying of the superficial hand vein occurred. A 25-gauge needle was inserted into a dorsal hand vein and a continuous infusion of physiological saline was started. The core was placed over the center of the vein about 10 mm downstream from the tip of needle. The voltage output was recorded on a strip chart recorder (Linearcorder Mark VII; Graphtec, Yokohama, Japan). Ten minutes after the insertion of the needle, increasing doses (from 1 to 512 ng/min) of noradrenaline (Nor-Adrenalin ® , Sankyo, Tokyo) were infused into the dorsal hand vein and recordings of the position of the core were made before and after inflation of a sphygmomanometer cuff on the same arm to 45 mmHg. Drug infusion lasted for 5 min and the cuff was inflated for the last 1 min during each infusion period.
Study Protocol
Subjects were instructed to refrain from caffeinecontaining and alcoholic beverages from 12 h before the start of the study. No breakfast was taken on the study days. The study was carried out as a single, blind, placebocontrolled, 3 period cross-over study with an interval of 1-2 weeks. The subjects received a single oral dose of 10 mg of amezinium metilsulfate (amezinium) (Rismic ® , Dainippon, Osaka, Japan), 2 mg of midodrine hydrochloride (midodrine) (Metligine ® , Taisyo, Tokyo, Japan), which are the recommended starting doses in Japan for these drugs, 11, 12 or a placebo. Two and half hours after amezinium, around the tmax of the drug, 13 1.5h after midodrine, around the tmax of its active metabolite, dimethoxyphenylaminoethanol, 14 or 2 h after placebo, the finger-tip skin vasoconstrictor response to cold stimulation was assessed, followed by assessment of the venoconstrictor response to noradrenaline infusion. The measurements started around 10.30 h. Between the preceding assessments (ie around 2 h and 50 min after amezinium, 1 hour and 50 min after midodrine, and 2 h and 20 min after the placebo) blood pressure and pulse rate were measured both in the supine position and 1 min after standing up, using a semiautomated sphygmomanometer (BP-103iII, Nihon Colin, Komaki, Japan). The experiments were performed in a room with the ambient temperature controlled at 24-26°C.
Data Evaluation
FTBF: Data were expressed in arbitrary units. Effects of contralateral hand cooling on FTBF were quantitated using the following equation:
where FTBFbef is the blood flow recorded just before the cold stimulation and FTBFmin is the minimum blood flow recorded during the cold stimulation. Dorsal Hand Vein Constriction: The individual doseresponse curve was analyzed by the following equation:
where x is the infusion rate of noradrenaline, Emax is the maximum venoconstrictor effect, and ED50 is the infusion rate producing a half-maximum response. The data were fitted to this equation by the least-squares method, providing estimates of ED50 and Emax.
Data are expressed as mean ± SD. Statistical analysis for the differences between the drugs and placebo were performed by analysis of variance (ANOVA) followed by Scheffe's multi-range test. A probability value of p<0.05 was considered as significant.
Results
Blood Pressure and Pulse Rate
Blood pressure and pulse rate in the supine position and 1 min after standing up are shown in Table 1 . No significant differences were observed between placebo and drug treatments in any of these parameters.
FTBF Measurements
There were no significiant differences in the FTBF (Fig 1) .
Venoconstrictor Response to Noradrenaline
Dose-response curves for the effect of noradrenaline infusion on dorsal hand vein constriction after the 3 treatments are shown in Fig 2. The values of the Emax for the 3 treatments were comparable. However, after amezinium but not after midodrine treatment, ED50 was significantly (p< 0.05) decreased compared with that of placebo ( Table 2) .
Discussion
Drugs used for the treatment of orthostatic hypotension include fludrocortisone acetate, a synthetic mineralcorticoid, 15 inhibitors of prostaglandin synthesis, such as indomethacin, 16 phenylpropanolamine, a sympathomimetic agent, 17 and caffeine. 18 -Blockers 19 and disopyramide 20 are effective for vasovagal syncope, a common cause of faintness. In Japan, amezinium 11, 21 and midodrine, 22, 23 both of which are vasoconstricting agents, are widely used for various type of orthostatic hypotension because of their excellent safety and good efficacy.
Orthostatic hypotension is induced by a variety of disorders, including inadequate vasoconstrictor response to sympathetic stimulation on standing. 3, 4 Therefore, it is interesting to investigate the effects of the drugs on vasoconstrictor reponse to sympathetic or adrenoceptor stimulations. In the present study, we examined whether the drugs have such effects or not in normal subjects using 2 noninvasive methods. This is a new approach to evaluating the drugs used for orthostatic hypotension.
First, the finger-tip vasoconstrictor response to cold stimulation was examined using a laser Doppler flowmeter. Laser Doppler analysis allows real-time and noninvasive measurement of skin blood circulation. 7 We used an integrating probe employing a bundle of 7 efferent fibers, which increases the total measuring volume in order to allow a more precise detection of the blood flow. 24 Although measurements obtained with a laser Doppler flowmeter are of a relative nature, the method is particularly appropriate for the study of local skin vasomotor responses in human subjects. 9, 25 Cold stimulation rapidly increases an endogenous noradrenaline concentration, which, in turn, causes -adrenoceptor-mediated vasoconstriction and a reduction in blood flow. 26 This method is used for the evaluation of autonomic failure, 25, 27, 28 including Shy-Drager syndrome, Parkinson's disease, amyloidosis and diabetic neuropathy. We demonstrated that 1-adrenoceptor antagonists, which could induce orthostatic hypotension, suppress the finger skin vasoconstrictor response and the degree of the suppression is correlated with the drug plasma concentration. 8 Second, the venoconstrictor response to noradrenaline was examined using LVDT. The dorsal hand vein technique provides a sensitive, easy and reproducible means of assessing the effect of drugs on peripheral veins. The effects of oral drugs on venoconstrictor response caused by the infusion of a vasoconstricting agent can be detected without affecting systemic hemodynamics, 9 because the measurement is made within the vicinity of the infusion site, allowing the amount of the agent to be extremely small. The venoconstrictor response of dorsal hand veins to phenylephrine or noradrenaline is reported to reflect the responsiveness of the foot vein 29 and the overall vascular system. 30 Several investigators have applied this method to the evaluation of the pathophysiological conditions of patients with orthostatic hypotension 31 or diabetic autonomic neuropathy. 32 Reproducibility of the finger-tip vasoconstrictor response to cold stimulation 33 and the venoconstrictor response to noradrenaline 34 were reported to be excellent. In the present study, we examined the vascular responses under standardized conditions including room temperature, time of the measurements and effect of food, to ensure the reliability of the experiments.
The 10 mg of amezinium and 2 mg of midodrine used in this study were the recommended starting oral doses in Japan for the treatment of orthostatic hypotension. The difference in pharmacokinetic properties of the drugs prompted us to select different time points for this single dose comparative study. As the tmax of amezinium 13 and that of dimethoxyphenyl-aminoethanol (DMAE), 14 an active metabolite of midodrine, are around 2.5 h and 1.5 h, respectively, the measurements were scheduled at 2.5 h, 1.5 h and 2 h after amezinium, midodrine, and placebo administration, respectively.
In the present study, the increase in blood pressure by amezinium or midodrine was not statistically significant. Other studies in healthy volunteers 13, 14 also showed that neither amezinium nor midodrine at the doses used in this study caused significant change in blood pressure or pulse rate. However, pretreatment with amezinium at the dose used in this study increased the finger-tip vasoconstrictor response to cold stimulation and venoconstrictor response to noradrenaline. These findings indicate that amezinium enhances vasoconstriction induced by sympathetic stimulation and venoconstriction induced by noradrenaline, and this mechanism by amezinium might contribute to the improvement of the symptoms of orthostatic hypotension. On the other hand, midodrine did not exert such an effect. The mechanism of these findings might be explained by the pharmacological properties obtained in in-vitro studies. Amezinium is shown to inhibit MAO activity inside noradrenergic neurons and the uptake of noradrenaline in the peripheral monoamine nervous system. 5, 6 Therefore, it can be speculated that the activity of noradrenaline released by cold stimulation and exogenously infused noradrenaline, which is inactivated by MAO, is enhanced by amezinium pretreatment. On the other hand, this study showed that midodrine did not affect the responsiveness of vasoconstriction to the stimulation, and this might be because it directly stimulates 1-adrenoceptors on blood vessels. 10 It would enhance vascular tone irrespective of the stimulation, although this phenomenon is hard to detect by the methods used in the present study. According to studies using the doral hand vein method, 31, 32 some patients with orthostatic hypotension show increased venoconstriction to exogenous noradrenaline due to denervation. Midodrine might be preferable in such patients, and this assumption is supported by a study in patients with diabetic orthostatic hypotension. 35 
Study Limitations
This study was performed in 8 healthy young subjects, using a single oral dose to characterize the properties of the drugs. Further studies are needed to elucidate whether the findings are similar after long treatment with the drugs and to evaluate the effects of the drugs on the vasoconstrictor responses as well as on blood pressure or symptoms due to hypotension in older subjects or in patients with various types of orthostatic hypotension.
From the findings observed in this study, amezinium might be effective for the treatment of patients with an impaired vasoconstrictor response. Applying the methods used in the present study in further investigations of the pathophysiology of orthostatic hypotension, in order to characterize the effects of the drugs in such patients, might give suggestions for the selection of the most appropriate drug in clinical practice.
Conclusion
In the present study, we showed, using a new approach, that a single oral dose of amezinium increases the vasoconstrictor response to sympathetic stimulation and exogenously infused noradrenaline in healthy subjects. Further studies are needed to evaluate this drug in patients with orthostatic hypotension.
